...
首页> 外文期刊>Journal of Medicinal Chemistry >Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D-1 Receptor Agonists
【24h】

Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D-1 Receptor Agonists

机译:为一类非儿茶酚多巴胺D-1受体激动剂定义结构功能性选择性关系(SFSR)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as beta-arrestins in addition to the canonical G protein-dependent pathways. GPCR ligands that differentially activate the downstream signaling pathways are termed functionally selective or biased ligands. A class of novel non-catechol G protein-biased agonists of the dopamine D-1 receptor (D1R) was recently disclosed. We conducted the first comprehensive structure-functional selectivity relationship study measuring G(s) and beta-arrestin2 recruitment activities focused on four regions of this scaffold, resulting in over 50 analogs with diverse functional selectivity profiles. Some compounds became potent full agonists of beta-arrestin2 recruitment, while others displayed enhanced G(s) bias compared to the starting compound. Pharmacokinetic testing of an analog with an altered functional selectivity profile demonstrated excellent blood-brain barrier penetration. This study provides novel tools for studying ligand bias at D1R and paves the way for developing the next generation of biased D1R ligands.
机译:G蛋白偶联受体(GPCR)能够通过不同的非甘露透道途径,例如β-incketins,除了规范的G蛋白依赖性途径之外,还能够下游信号传导。差异激活下游信号传导途径的GPCR配体被称为功能性选择性或偏置配体。最近公开了一类新型非儿茶酚G蛋白偏置的多巴胺D-1受体(D1R)的激动剂。我们进行了第一个综合结构功能选择性关系研究,该综合性术语和β-arrierin2招生活动的重点是该支架的四个区域,导致具有多种功能选择性型材的50多种类似物。一些化合物变得有效的β-捕获胞集募集的充满激动剂,而其他化合物与起始化合物相比,其他化合物展示了增强的G(S)偏差。具有改变功能选择性型材的模拟的药代动力学测试表明了优异的血脑屏障渗透。本研究提供了用于研究D1R的配体偏压的新型工具,并为开发下一代偏置D1R配体铺平道路。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2019年第7期|共20页
  • 作者单位

    Icahn Sch Med Mt Sinai Tisch Canc Inst Mt Sinai Ctr Therapeut Discovery Dept Pharmacol Sci New York NY 10029 USA;

    Icahn Sch Med Mt Sinai Tisch Canc Inst Mt Sinai Ctr Therapeut Discovery Dept Pharmacol Sci New York NY 10029 USA;

    Duke Univ Med Ctr Dept Cell Biol Durham NC 27710 USA;

    Icahn Sch Med Mt Sinai Tisch Canc Inst Mt Sinai Ctr Therapeut Discovery Dept Pharmacol Sci New York NY 10029 USA;

    Univ Florida Coll Med Dept Pharmacol &

    Therapeut Gainesville FL 32610 USA;

    Univ Florida Coll Med Dept Pharmacol &

    Therapeut Gainesville FL 32610 USA;

    Univ North Carolina Chapel Hill Sch Med Dept Pharmacol Chapel Hill NC 27599 USA;

    Duke Univ Med Ctr Dept Cell Biol Durham NC 27710 USA;

    Univ North Carolina Chapel Hill Sch Med Dept Pharmacol Chapel Hill NC 27599 USA;

    Icahn Sch Med Mt Sinai Tisch Canc Inst Mt Sinai Ctr Therapeut Discovery Dept Pharmacol Sci New York NY 10029 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号